Product Information
LURASIDONE HCL 40 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2095 per EA under NDC 65862095430. Its NADAC has been published 138 times since Feb 14, 2024.
FDA first approved this application on Mar 10, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862095430
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LURASIDONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208045FDA Approved
3/10/2023
TE Code
AB
On Market Since
3/10/2023
Pharmacological Classes
Price Statistics
The NADAC for LURASIDONE HCL 40 MG TABLET has been published 138 times since Feb 14, 2024, and over the history we have for it it has declined 33.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2095 per EA |
|---|---|
| All-time high | $0.3430 (Jul 10, 2024) |
| All-time low | $0.2002 (Nov 20, 2024) |
| 52-week high | $0.2775 |
| 52-week low | $0.2095 |
| Median price | $0.2761 |
| Average price | $0.2715 |
| Largest weekly change | -34.9% (Nov 20, 2024) |
| Weeks tracked | 138 |
| Tracking since | Feb 14, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the LURASIDONE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
LURASIDONE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LURASIDONE HCL 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LURASIDONE HCL 40 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.2095 per EA (NDC 65862095430), effective Sep 30, 2026.
How has the price of LURASIDONE HCL 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for LURASIDONE HCL 40 MG TABLET has declined 33.3%. It has been tracked across 138 weekly CMS publications since Feb 14, 2024.
What are the highest and lowest recorded NADAC prices for LURASIDONE HCL 40 MG TABLET?
Since Feb 14, 2024, the NADAC for LURASIDONE HCL 40 MG TABLET has ranged from a low of $0.2002 (Nov 20, 2024) to a high of $0.3430 (Jul 10, 2024), with a median of $0.2761 per EA.
Are there cheaper alternatives to LURASIDONE HCL 40 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of LURASIDONE HCL 40 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LURASIDONE HCL 40 MG TABLET?
LURASIDONE HCL 40 MG TABLET (NDC 65862095430) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.